Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEHZJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,033
Award facts
- Contract value 100% obligated
- $17,032.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,032.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a purchase of pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, with a completion date of December 31, 2036. The PPV-G GEN V represents a comprehensive $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors capable of supplying the full range of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables required by military healthcare facilities worldwide. DMS Pharmaceutical Group's established portfolio includes specialty pharmaceuticals, oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals, positioning the company as a critical supplier within the Department of Defense's global pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEHZJ?
SPE2DU26FEHZJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DU26FEHZJ worth?
The government has obligated $17,033 on SPE2DU26FEHZJ.
Is contract SPE2DU26FEHZJ an order under another contract?
Yes. SPE2DU26FEHZJ is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZJ competed?
The extent of competition for SPE2DU26FEHZJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award